Dasatinib is a tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia. However, the drug may contain impurities that can affect its safety and efficacy. Dasatinib impurities are substances that are present in the drug in small amounts, but can have harmful effects on the human body. These impurities can be generated during the manufacturing process or may be present in the raw materials used to make the drug. It is important to monitor and
